Work

Abstract A025-PR001: The potential of BCL-xL degradation as a strategy to eliminate chemotherapy-resistant neuroblastoma persister cells

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.pediatric25-a025-pr001

Authors: Matteo Calafatti, Emily Mycek, Dana Al-halawani, Josh Kalna, David Groff, Esther Coronado Mondragón, Patel Khushbu, Mark Gerelus, Jarrett Lindsay, Kyabeth Torres-rodriguez, Gregory Connelly, Smita Matkar, Sajid Khan, Zhengyu Wang, Hong Yu Li, Jaime Font de Mora, Yael P Mossé, Daohong Zhou, Liron Grossmann, John M Maris

Institutions: Children's Hospital of Philadelphia, The University of Texas at San Antonio Health Science Center, University of Pennsylvania, Sheba Medical Center, Edmond and Lily Safra Children's Hospital

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414532506

Cites:

Cited by:

Related to: